Fundz

Clade Therapeutics, Inc. reported raising $45.9 Million in an initial SEC Form D filing, from an offering of $87.1 Million

PRIVATENov 12, 2021$45.9M of $87.1M raised

Amount Raised

$45.9 Million

$45.9 Million sold, per SEC Form D (first sale Nov 12, 2021)

Round Type

Venture

BostonBiotechnologyHealthcare

Quick answer

Clade Therapeutics raised $45.9 Million in a funding round, dated November 12, 2021. Clade Therapeutics is based in Boston, Massachusetts, United States.

How much did Clade Therapeutics raise?
Clade Therapeutics raised $45.9 Million in a funding round on November 12, 2021.
What does Clade Therapeutics do?
Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases.
Where is Clade Therapeutics based and how big is it?
Clade Therapeutics is based in Boston, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Clade Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • BIOTRICITY INC. raised $12M (Debt Financing) on December 27, 2021.
  • EIP Pharma, Inc. raised $6M on December 23, 2021.
  • Vero Biotech Inc. raised $27M on December 22, 2021.
  • Vero Biotech Inc. raised an undisclosed amount (Funding Round) on December 21, 2021.
  • Galectin raised an undisclosed amount (Debt Financing) on December 21, 2021.
  • Lexaria Bioscience raised $1.2M on December 20, 2021.

Who to call at Clade Therapeutics, and when

A new round usually means Clade Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Clade Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Clade Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Clade Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Clade Therapeutics

Location

Boston, Massachusetts, United States

About

Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located in the heart of Cambridge was recently launched by an exceptional group of academic leaders and successful bioentrepreneurs converging stem cell biology, immunology, regenerative medicine, and gene editing into the next-generation of stem cell-derived medicines.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Clade Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Clade Therapeutics's next move

See what Strategic adds

Clade Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.